Over the past decade, clinical trials for new drugs, treatments and medical devices have increasingly been conducted in countries overseas. Emerging markets offer attractive benefits to sponsors, including significant cost reductions, easier recruitment and faster study completion. Top countries for outsourcing clinical research include India, China and Russia.
The need for quality medical translation grows as more clinical trials are conducted in emerging nations. Clinical research accounts for a significant percentage of the cost of bringing a new drug to market, but poor-quality translation during the trial period can incur even more significant costs. Put simply, the wrong translation provider can compromise an entire study. Read more